Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentBeginning Cash BalanceCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Journey Medical (DERM) Share-based Compensation: 2020-2024

Historic Share-based Compensation for Journey Medical (DERM) over the last 5 years, with Dec 2024 value amounting to $6.1 million.

  • Journey Medical's Share-based Compensation rose 13.05% to $1.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.9 million, marking a year-over-year increase of 12.23%. This contributed to the annual value of $6.1 million for FY2024, which is 134.00% up from last year.
  • Per Journey Medical's latest filing, its Share-based Compensation stood at $6.1 million for FY2024, which was up 134.00% from $2.6 million recorded in FY2023.
  • Over the past 5 years, Journey Medical's Share-based Compensation peaked at $6.1 million during FY2024, and registered a low of $153,000 during FY2020.
  • For the 3-year period, Journey Medical's Share-based Compensation averaged around $4.4 million, with its median value being $4.4 million (2022).
  • In the last 5 years, Journey Medical's Share-based Compensation spiked by 1,511.76% in 2021 and then crashed by 41.11% in 2023.
  • Journey Medical's Share-based Compensation (Yearly) stood at $153,000 in 2020, then skyrocketed by 1,511.76% to $2.5 million in 2021, then surged by 79.44% to $4.4 million in 2022, then plummeted by 41.11% to $2.6 million in 2023, then skyrocketed by 134.00% to $6.1 million in 2024.